1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Long-term efficacy and safety of tildrakizumab: 5-year results from the reSURFACE 1 and 2 Phase III trials in patients with moderate-to-severe plaque psoriasis

      EMJ Dermatol

      Read this article at

      ScienceOpen
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Comments

          Comment on this article